Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell-depleted lymphoma after CART therapy.

Saved in:
Bibliographic Details
Title: Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell-depleted lymphoma after CART therapy.
Authors: Atanackovic D; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD., Luetkens T; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD., Omili D; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD., Iraguha T; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD., Lutfi F; Department of Oncology/Hematology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD., Hardy NM; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD., Fan X; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD.; Department of Oncology/Hematology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD., Avila SV; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD., Saharia KK; Institute of Human Virology.; Divison of Infectious Diseases, and., Husson JS; Institute of Human Virology.; Divison of Infectious Diseases, and., Niederhaus SV; Department of Surgery, University of Maryland School of Medicine, Baltimore, MD; and., Margiotta P; Department of Oncology/Hematology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD., Lee ST; Department of Oncology/Hematology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD., Law JY; Department of Oncology/Hematology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD., Mannuel HD; Department of Oncology/Hematology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Department of Oncology/Hematology, Baltimore Veterans Affairs Medical Center, Baltimore, MD., Vander Mause E; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD., Bauman S; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD., Lesho P; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD., Hankey K; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD., Baddley J; Department of Oncology/Hematology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Institute of Human Virology.; Divison of Infectious Diseases, and., Kocoglu M; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD., Yared JA; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD., Rapoport AP; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD., Dahiya S; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.
Source: Blood [Blood] 2022 Jul 14; Vol. 140 (2), pp. 152-156.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1528-0020
DOI:10.1182/blood.2022016175